These findings combined pathological and genetic insight and established the disease concept of “synucleinopathy.” Wakabayashi and colleagues reported that the major protein component in GCI was also α-synuclein, linking MSA and Lewy body disease as the two major clinicopathologic subtypes of synucleinopathy [22]. The gene discussed is SNCA; the disease is synucleinopathy.